DIAGENS-B Shares Surge Over 15% to Record High Following Debut of Proprietary Medical Imaging Model at Canton Fair

Stock News05-04 10:35

DIAGENS-B (02526) saw its shares rise more than 15% during the morning session, reaching a record high of HK$335. This represents an increase of nearly 240% compared to its IPO price of HK$99. As of the time of writing, the stock was up 11.81% at HK$322, with a turnover of HK$37.38 million.

The surge follows the company's participation in the third phase of the 139th Canton Fair, which opened in Guangzhou on May 1. The event featured a dedicated Smart Healthcare zone showcasing cutting-edge technologies in the global medical health sector. DIAGENS-B presented its self-developed iMedImage® medical imaging foundation model at the fair, attracting significant attention. Its booth was crowded with buyers from regions including the Middle East, Southeast Asia, and Europe, who showed strong interest in its technology and products.

A recent analysis highlighted that DIAGENS-B's 2025 annual report serves as a powerful demonstration of its capabilities. A 332% surge in technology licensing revenue validates the feasibility of its large model commercial loop. The company maintains a dominant position in a policy-driven essential sector with a 30.6% market share. Furthermore, the endorsement of the iMedImage® foundation model by leading institutions such as Tencent underscores its strategic value as a global AI medical infrastructure service provider.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1147735212?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-04 10:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1147735212","market":"fut","top_or_hot":-1,"title":"DIAGENS-B Shares Surge Over 15% to Record High Following Debut of Proprietary Medical Imaging Model at Canton Fair","media":"Stock News","content":"<p>DIAGENS-B (02526) saw its shares rise more than 15% during the morning session, reaching a record high of HK$335. This represents an increase of nearly 240% compared to its IPO price of HK$99. As of the time of writing, the stock was up 11.81% at HK$322, with a turnover of HK$37.38 million.</p>\n<p>The surge follows the company's participation in the third phase of the 139th Canton Fair, which opened in Guangzhou on May 1. The event featured a dedicated Smart Healthcare zone showcasing cutting-edge technologies in the global medical health sector. DIAGENS-B presented its self-developed iMedImage® medical imaging foundation model at the fair, attracting significant attention. Its booth was crowded with buyers from regions including the Middle East, Southeast Asia, and Europe, who showed strong interest in its technology and products.</p>\n<p>A recent analysis highlighted that DIAGENS-B's 2025 annual report serves as a powerful demonstration of its capabilities. A 332% surge in technology licensing revenue validates the feasibility of its large model commercial loop. The company maintains a dominant position in a policy-driven essential sector with a 30.6% market share. Furthermore, the endorsement of the iMedImage® foundation model by leading institutions such as Tencent underscores its strategic value as a global AI medical infrastructure service provider.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>DIAGENS-B Shares Surge Over 15% to Record High Following Debut of Proprietary Medical Imaging Model at Canton Fair</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDIAGENS-B Shares Surge Over 15% to Record High Following Debut of Proprietary Medical Imaging Model at Canton Fair\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-05-04 10:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>DIAGENS-B (02526) saw its shares rise more than 15% during the morning session, reaching a record high of HK$335. This represents an increase of nearly 240% compared to its IPO price of HK$99. As of the time of writing, the stock was up 11.81% at HK$322, with a turnover of HK$37.38 million.</p>\n<p>The surge follows the company's participation in the third phase of the 139th Canton Fair, which opened in Guangzhou on May 1. The event featured a dedicated Smart Healthcare zone showcasing cutting-edge technologies in the global medical health sector. DIAGENS-B presented its self-developed iMedImage® medical imaging foundation model at the fair, attracting significant attention. Its booth was crowded with buyers from regions including the Middle East, Southeast Asia, and Europe, who showed strong interest in its technology and products.</p>\n<p>A recent analysis highlighted that DIAGENS-B's 2025 annual report serves as a powerful demonstration of its capabilities. A 332% surge in technology licensing revenue validates the feasibility of its large model commercial loop. The company maintains a dominant position in a policy-driven essential sector with a 30.6% market share. Furthermore, the endorsement of the iMedImage® foundation model by leading institutions such as Tencent underscores its strategic value as a global AI medical infrastructure service provider.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02251","symbol_name":"鹰瞳科技-B","start_time":0,"source_url":"","article_id":"1147735212","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1147735212","pubTimestamp":1777862108,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"DIAGENS-B (02526) saw its shares rise more than 15% during the morning session, reaching a record high of HK$335. This represents an increase of nearly 240% compared to its IPO price of HK$99. As of...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02251":"鹰瞳科技-B","IPOS":"Renaissance International IPO ETF","BK4588":"碎股","BK1100":"医疗保健设备","BK4585":"ETF&股票定投概念","BK1189":"医疗保健技术","VXUS":"国际股票ETF-Vanguard","02526":"德适-B"},"translate_title":"专有医学成像模型在广交会首次亮相后，DIAGENS-B股价飙升逾15%，创历史新高","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02526":1,"IPOS":1,"02251":1,"VXUS":1},"content_text":"DIAGENS-B (02526) saw its shares rise more than 15% during the morning session, reaching a record high of HK$335. This represents an increase of nearly 240% compared to its IPO price of HK$99. As of the time of writing, the stock was up 11.81% at HK$322, with a turnover of HK$37.38 million.\nThe surge follows the company's participation in the third phase of the 139th Canton Fair, which opened in Guangzhou on May 1. The event featured a dedicated Smart Healthcare zone showcasing cutting-edge technologies in the global medical health sector. DIAGENS-B presented its self-developed iMedImage® medical imaging foundation model at the fair, attracting significant attention. Its booth was crowded with buyers from regions including the Middle East, Southeast Asia, and Europe, who showed strong interest in its technology and products.\nA recent analysis highlighted that DIAGENS-B's 2025 annual report serves as a powerful demonstration of its capabilities. A 332% surge in technology licensing revenue validates the feasibility of its large model commercial loop. The company maintains a dominant position in a policy-driven essential sector with a 30.6% market share. Furthermore, the endorsement of the iMedImage® foundation model by leading institutions such as Tencent underscores its strategic value as a global AI medical infrastructure service provider.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1147735212","isCrawlerRequest":true}